NHS National Framework Agreement for Adalimumab Injection
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £125,000,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | North East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West |
| Deadline | 17 Feb 2020 |
| Contract start | 1 Apr 2020 |
| Contract end | 31 Mar 2022 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-f96f894b-efb7-43e5-a819-406e064cdcb2 |
Awards (4)
This procurement was awarded to 4 suppliers. Values shown are per-award; the notice total is £125,000,000.
| Supplier | Value | Date | Status |
|---|---|---|---|
| AbbVie Ltd shared | £445,000,000 | 6 Mar 2020 | active |
| Amgen Ltd. shared | £445,000,000 | 6 Mar 2020 | active |
| Biogen Ltd. shared | £445,000,000 | 6 Mar 2020 | active |
| Fresenius Kabi Limited shared | £445,000,000 | 6 Mar 2020 | active |
description
NHS Framework Agreement for Adalimumab Injection
Offer reference number: CM/PHR/19/5575
Period of Framework Agreement:
- April 2020 - 31 March 2022 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
documents
- https://nhsengland.bravosolution.co.uk , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/ce3e6bb6-3951-4f58-ad3a-4e5ed766d0e8 , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 21 May 2020 | Award (award) | · | 0ed6ad81-db81-4d2a-a3c2-d8917c178742-360114 |
more from NHS England
- Urgent Award - haematological screening · £16,202 · 29 Jul 2026
- HSCN-AWS Connectivity Service for Spine · £228,060 · 29 Jul 2026
- Incentive Voucher Provider · £60,000 · 29 Jul 2026
- CRM for NHSE participant/candidate data 26-27 · £56,640 · 28 Jul 2026
- Wayfinder and First Contact Digital Clinical Support 2026-27 · £748,000 · 23 Jul 2026
- Support Services for PPM application · £860,000 · 22 Jul 2026
- Digital Maturity Assessment · 21 Jul 2026
- Integrated Healthcare Services to Haslar Immigration Removal Centre (IRC) · £19,052,186 · 13 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.